Hookipa Pharma Net Income

Hookipa Pharma (HOOK) currently reports a net income of $-56M as of June 2025. That compares with $-49M in the prior-year period — down 15.2% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Hookipa Pharma's net income history and peer comparisons.

Hookipa Pharma's net income decreased from $-49M to $-56M — a 15.2% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hookipa Pharma's net income of $-56M is lower than the Healthcare sector average of $17B. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Hookipa Pharma reported $-56M in net income as of June 2025. That compares with $-49M in the prior-year period — down 15.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-56M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Hookipa Pharma, and consider following HOOK for alerts when major investors trade the stock.